scanX
Home
Lyka Labs

Lyka Labs

142.00
-3.87
(-2.65%)
Market Cap (₹ Cr.)
₹518
52 Week High
172.50
Book Value
₹20
52 Week Low
97.90
PE Ratio
495.19
PB Ratio
5.43
PE for Sector
38.75
PB for Sector
4.65
ROE
-3.84 %
ROCE
3.32 %
Dividend Yield
0.00 %
EPS
₹0.26
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
16.77 %
Net Income Growth
80.08 %
Cash Flow Change
-80.22 %
ROE
86.67 %
ROCE
407.78 %
EBITDA Margin (Avg.)
-27.35 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
19
27
27
21
23
14
23
23
19
7
9
16
12
12
6
10
16
7
9
13
11
13
13
20
19
44
66
29
28
23
23
18
20
22
27
32
27
31
Expenses
15
22
18
16
17
12
18
17
13
9
12
12
11
12
7
9
13
6
8
41
12
11
11
14
14
14
23
16
19
16
18
22
17
19
23
26
25
26
EBITDA
4
6
8
5
6
2
5
6
7
-2
-3
4
1
0
-0
1
2
0
1
-28
-1
2
3
5
5
30
43
13
9
7
6
-4
3
3
4
6
3
5
Operating Profit %
16 %
14 %
7 %
8 %
9 %
15 %
20 %
26 %
31 %
-33 %
-49 %
21 %
-0 %
-1 %
-10 %
2 %
8 %
4 %
8 %
-243 %
-21 %
15 %
19 %
24 %
21 %
69 %
65 %
42 %
32 %
27 %
21 %
-27 %
13 %
12 %
15 %
19 %
8 %
13 %
Depreciation
0
1
1
1
1
1
1
1
2
1
2
2
2
2
2
1
1
1
1
2
2
2
2
2
2
2
2
2
9
3
3
3
3
3
3
3
3
2
Interest
4
4
4
3
4
4
4
4
3
4
4
1
-4
1
1
1
2
1
1
11
6
6
6
7
6
7
6
5
3
3
3
3
3
1
1
1
1
1
Profit Before Tax
-0
0
3
0
1
-3
-0
1
2
-8
-9
1
3
-2
-3
-1
-1
-2
-1
-41
-9
-6
-6
-3
-4
21
35
6
-3
0
-1
-10
-3
-2
-0
2
-1
2
Tax
0
0
0
0
0
0
-0
-0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
-0
0
0
1
0
0
Net Profit
-0
0
3
0
1
-3
0
1
2
-8
-9
1
3
-2
-3
-1
8
-2
-1
-42
-10
-6
-6
-3
0
20
30
6
-15
0
-0
-10
-3
-2
-0
1
-2
2
EPS in ₹
-0.18
0.10
1.46
0.19
0.53
-1.21
0.00
1.04
0.79
-3.43
-3.79
0.36
1.12
-0.82
-1.09
-0.57
2.73
-0.87
-0.43
-14.64
-3.49
-2.03
-2.04
-1.08
0.07
6.84
10.38
1.97
-5.32
0.11
-0.15
-3.57
-1.05
-0.54
-0.10
0.40
0.50
0.49
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
233
228
243
245
249
221
213
209
179
186
Fixed Assets
62
60
86
81
76
102
95
90
66
56
Current Assets
64
59
48
53
49
31
26
47
42
50
Capital Work in Progress
27
30
24
26
30
26
24
18
16
23
Investments
0
0
62
62
62
32
32
32
32
32
Other Assets
144
138
70
75
80
61
61
68
65
75
Total Liabilities
172
162
169
148
150
202
209
164
102
87
Current Liabilities
140
134
131
140
68
55
45
94
30
36
Non Current Liabilities
32
27
38
8
82
147
164
70
72
51
Total Equity
61
67
74
97
99
19
4
44
76
99
Reserve & Surplus
38
43
52
69
70
-10
-24
16
46
66
Share Capital
23
23
22
28
28
29
29
29
31
33
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-3
0
-0
-1
-0
8
-2
9
-7
-3
Investing Activities
30
5
-5
-3
-3
0
0
-4
7
-9
Operating Activities
29
8
20
7
18
-11
6
77
7
3
Financing Activities
-63
-13
-15
-4
-16
20
-8
-63
-20
3
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Apr 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Promoter
19.88 %
19.88 %
20.00 %
20.04 %
47.79 %
47.80 %
47.59 %
47.59 %
51.00 %
54.56 %
54.58 %
54.81 %
54.81 %
54.81 %
58.10 %
58.10 %
FIIs
3.50 %
3.50 %
2.07 %
1.13 %
1.12 %
0.76 %
0.57 %
0.37 %
0.18 %
0.17 %
0.17 %
0.18 %
0.17 %
0.17 %
0.16 %
0.15 %
DIIs
0.47 %
0.47 %
1.85 %
0.47 %
1.19 %
4.00 %
4.00 %
4.00 %
3.74 %
3.09 %
0.41 %
0.41 %
0.62 %
0.88 %
0.82 %
0.75 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
76.15 %
76.15 %
76.08 %
78.36 %
49.89 %
47.45 %
47.84 %
48.05 %
45.08 %
42.19 %
44.85 %
44.60 %
44.40 %
44.13 %
40.92 %
40.99 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
Biocon
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
44.39
ATR(14)
Less Volatile
7.77
STOCH(9,6)
Neutral
21.91
STOCH RSI(14)
Oversold
3.18
MACD(12,26)
Bearish
-2.31
ADX(14)
Strong Trend
25.19
UO(9)
Bearish
34.10
ROC(12)
Downtrend And Accelerating
-8.36
WillR(14)
Oversold
-95.49
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.